Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ilaria Laface
Tumoral and Immune Heterogeneity in an Anti-Pd-1 Responsive Glioblastoma: A Case Study
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
Related publications
Effect of Combined Anti-Pd-1 and Temozolomide Therapy in Glioblastoma
OncoImmunology
Oncology
Allergy
Immunology
P3.09-05 Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice
Cancer immunology research
Cancer Research
Immunology
Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model
International Journal of Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme
BMC Cancer
Cancer Research
Oncology
Genetics
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Expression of LAG-3 and Efficacy of Combination Treatment With Anti-Lag-3 and Anti-Pd-1 Monoclonal Antibodies in Glioblastoma
International Journal of Cancer
Cancer Research
Oncology
Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-Pd-1 Therapy
Cancer Research
Cancer Research
Oncology